Anonymous
Guest
Anonymous
Guest
This financial analyst has made an interesting assessment of our pipeline. The article says that Lilly's "product portfolio looks like a graveyard". What return have we gotten on the $11 billion that John has spent on acquisitions to improve our pipeline? Could there not be a better example of business incompetence? There's a distinct difference between "being well educated" and "being smart". And what does this say about the Board of Directors who have been overseeing John's performance? How can a handful of people bring down a $20 billion dollar enterprise in just a few short years? Are there no Lilly leaders with the guts to tell the emperor that he has no clothes? We're all like frogs sitting in the pot of water on the stove about to be boiled.
http://www.fool.com/investing/general/2011/04/22/pharmas-most-perilous-pipelines.aspx
http://www.fool.com/investing/general/2011/04/22/pharmas-most-perilous-pipelines.aspx